IP Library Granted Patent US 8,435,963
Granted Patent B2
US 8,435,963 · App. 12/567,323 · Granted May 7, 2013

Weight loss compositions and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,435,963
App. No.
12/567,323
Granted
May 7, 2013
Kind
B2
Abstract

This invention provides unique and advantageous formulations and methods for weight loss.

Claims (30)

1. A composition for inducing weight loss wherein said composition consists essentially of:

a) yohimbine;

b) 11-hydroxy yohimbine;

c) alpha-yohimbine;

d) methyl synephrine;

e) R-beta methylphenylethylamine;

f) n-methyl beta methylphenylethylamine and/or n-methyl beta phenylethylamine;

g) methyl hordenine; and

h) methyl tetradecylthioacetic acid.

2. A composition for inducing weight loss wherein said composition consists of:

a) yohimbine;

b) 11-hydroxy yohimbine;

c) alpha-yohimbine;

d) methyl synephrine;

e) R-beta methylphenylethylamine;

f) n-methyl beta methylphenylethylamine and/or n-methyl beta phenylethylamine;

g) methyl hordenine;

h) methyl tetradecylthioacetic acid; and, optionally,

one or more further ingredients selected from the group consisting of caffeine, cAMP, water, flavoring agents, colorants, viscosity modifiers, preservatives, fragrances, vitamins, minerals, enzymes, co-enzymes, emulsifiers, stabilizers, flow modifiers, viscosity improvers, chelating agents, anti-oxidants, anti-microbials, alcohols, propionates, and surfactants.

3. A method of inducing weight loss in a mammal, comprising administering to said mammal a weight loss inducing amount of the composition of claim 1 .

4. A composition for inducing weight loss wherein said composition consists essentially of:

a) yohimbine;

b) 11-hydroxy yohimbine;

c) alpha-yohimbine;

d) methyl synephrine;

e) R-beta methylphenylethylamine;

f) n-methyl beta methylphenylethylamine and/or n-methyl beta phenylethylamine;

g) methyl hordenine;

h) methyl tetradecylthioacetic acid; and

one or more ingredients selected from the group consisting of caffeine, cAMP, water, flavoring agents, colorants, viscosity modifiers, preservatives, fragrances, vitamins, minerals, enzymes, co-enzymes, emulsifiers, stabilizers, flow modifiers, viscosity improvers, chelating agents, anti-oxidants, anti-microbials, alcohols, propionates, and surfactants.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2023
From: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
To: VITAL PHARMACEUTICALS, INC.
Reel/Frame 065335/0726 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2023
From: VITAL PHARMACEUTICALS, INC.; VITAL PHARMACEUTICALS INTERNATIONAL SALES, INC.
To: ENERGY BEVERAGES LLC
Reel/Frame 065336/0001 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Aug 18, 2020
From: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
To: TRUIST BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 053532/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2015
From: 4141 HOLDINGS, LLC; OWOC, JACK H
To: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
Reel/Frame 035474/0712 →